Diffusion MRI quality control and functional diffusion map results in ACRIN 6677/RTOG 0625: A multicenter, randomized, phase II trial of bevacizumab and chemotherapy in recurrent glioblastoma

Author： Ellingson Benjamin M.   Kim Eunhee   Woodworth Davis C.   Marques Helga   Boxerman Jerrold L.   Safriel Yair   McKinstry Robert C.   Bokstein Felix   Jain Rajan   Chi T. Linda   Sorensen A. Gregory   Gilbert Mark R.   Barboriak Daniel P.  

Publisher： Spandidos Publications

E-ISSN： 1791-2423|46|5|1883-1892

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.46, Iss.5, 2015-05, pp. : 1883-1892

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy

By Reardon David   Desjardins Annick   Peters Katherine   Gururangan Sridharan   Sampson John   Rich Jeremy   McLendon Roger   Herndon James   Marcello Jennifer   Threatt Stevie   Friedman Allan   Vredenburgh James   Friedman Henry  

Journal of Neuro-Oncology, Vol. 103, Iss. 2, 2011-06 ,pp. : 371-379

Springer Publishing Company

Access to resources Recommend Favorite

Induction of a Pathological Complete Response by Four Courses of Neoadjuvant Chemotherapy for Gastric Cancer: Early Results of the Randomized Phase II COMPASS Trial

By Yoshikawa Takaki   Tanabe Kazuaki   Nishikawa Kazuhiro   Ito Yuichi   Matsui Takanori   Kimura Yutaka   Hirabayashi Naoki   Mikata Shoki   Iwahashi Makoto   Fukushima Ryoji   Takiguchi Nobuhiro   Miyashiro Isao   Morita Satoshi   Miyashita Yumi   Tsuburaya Aakira   Sakamoto Junichi  

Annals of Surgical Oncology, Vol. 21, Iss. 1, 2014-01 ,pp. : 213-219

Springer Publishing Company

Access to resources Recommend Favorite

Multicenter phase II randomized trial evaluating antiangiogenic therapy with sunitinib as consolidation after objective response to taxane chemotherapy in women with HER2-negative metastatic breast cancer

By Wildiers H.  

Breast Cancer Research and Treatment, Vol. 123, Iss. 2, 2010-09 ,pp. : 463-469

Springer Publishing Company

Access to resources Recommend Favorite

The efficacy and safety of palonosetron compared with granisetron in preventing highly emetogenic chemotherapy-induced vomiting in the Chinese cancer patients: a phase II, multicenter, randomized, double-blind, parallel, comparative clinical trial

By Yu Zhaocai  

Supportive Care in Cancer, Vol. 17, Iss. 1, 2009-01 ,pp. : 99-102

Springer Publishing Company

Access to resources Recommend Favorite

Effects of exercise dose and type on sleep quality in breast cancer patients receiving chemotherapy: a multicenter randomized trial

By Courneya Kerry   Segal Roanne   Mackey John   Gelmon Karen   Friedenreich Christine   Yasui Yutaka   Reid Robert   Jespersen Diana   Cook Diane   Proulx Carolyn   Trinh Linda   Dolan Lianne   Wooding Evyanne   Forbes Cynthia   McKenzie Donald  

Breast Cancer Research and Treatment, Vol. 144, Iss. 2, 2014-04 ,pp. : 361-369

Springer Publishing Company

Access to resources Recommend Favorite